Avigena Launches Boston Office to Advance Preventive Genomic Medicine in the MENA Region
October, 2025
Boston, MA — October 2025 — Avigena, a U.S.-based genomic medicine company, officially
launched its Boston office in October 2025, marking a key milestone in its global expansion.
The launch took place in the presence of Avigena Co-Founders Fadi Bitar and Akl Fahed.
Through its Boston hub, Avigena aims to introduce advanced genomic prediction and prevention
services to the Middle East and North Africa (MENA) region, while building sustainable
programs that strengthen healthcare systems and improve the health and lives of people across
the region.
Avigena’s mission is to empower individuals and healthcare professionals with accurate,
accessible, and actionable genomic insights to support informed decisions in health, wellness,
and disease prevention.